Amoxil, a bactericidal antibiotic based on amoxicillin, is registered in 21 countries and is used for the treatment of a range of bacterial infections. The brand sits within the broader penicillin family, one of the oldest and most widely prescribed antibiotic categories in global medicine, and remains a familiar name to clinicians and patients in many parts of the world.
The registered indications for Amoxil span several common infection types, including bronchitis, community-acquired pneumonia, middle ear infection, abscess, gonorrhoea, and Lyme disease. The structured indication list further down this page reflects the uses recognised by national regulators in the markets where Amoxil is sold. Amoxicillin's role as a bactericidal agent is what places it in the antibacterial category covered by these indications.
Amoxil's country footprint is geographically scattered rather than regionally concentrated, with marketing authorisation across markets such as Brazil, India, Australia, Greece, Kenya, and Peru. Travellers and expatriates moving between these markets may find the same Amoxil brand on pharmacy shelves, while in countries where the brand is not registered, amoxicillin itself is almost always available — typically under a different brand name or as a generic, since the molecule has long been off-patent and is produced by a wide range of manufacturers worldwide.
Other antibiotics in the penicillin family and in adjacent antibacterial classes are also distributed internationally, though they are not interchangeable without clinical guidance. Antibiotic prescribing rules and over-the-counter availability differ markedly between countries, and resistance patterns are local. Anyone using or considering Amoxil should rely on a healthcare provider for prescribing decisions, and a pharmacist abroad can help identify the appropriate amoxicillin-containing product in their market.
Amoxil is prescribed for a range of bacterial infections, including bronchitis, community-acquired pneumonia, middle ear infection, abscess, gonorrhoea, and Lyme disease. As a bactericidal antibiotic, it acts against susceptible bacteria responsible for these conditions. The full registered indication list, as recognised in the markets where Amoxil is sold, is shown in the structured data section below this introduction.
The active ingredient is amoxicillin, a bactericidal antibiotic belonging to the broader penicillin family. Amoxicillin is one of the most widely circulated antibiotic molecules in the world and is sold under a number of different brand names depending on the country, both as a single-ingredient product and in fixed-dose combinations with other antibacterial agents.
Amoxil is registered in 21 countries, with a geographically diverse footprint that includes Brazil, India, Australia, Kenya, Greece, Lebanon, and Peru. If your country is not represented on this list, amoxicillin itself is available in essentially every regulated market worldwide, and a local pharmacist can identify the equivalent amoxicillin-containing product carried locally.
Amoxicillin is sold under many brand names internationally, and is one of the most commonly prescribed antibiotics in the world. Other bactericidal antibiotics — both within the penicillin family and in adjacent classes — also exist, although they are not freely interchangeable, since spectrum of activity and clinical positioning differ. To find a local amoxicillin product, search the active ingredient on Pill2Trip or ask a pharmacist.
Yes. Antibiotics are prescription medications in most jurisdictions, and the choice of antibiotic, as well as the decision to use one at all, depends on the specific infection, patient history, and local resistance patterns. This is particularly relevant for travellers, since prescription requirements and over-the-counter availability of antibiotics vary considerably between countries. A healthcare provider should lead any decision to start, change, or substitute therapy.
